简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2015-12-09 10:10
Arcadia Biosciences and BGI to Create Global Non-GM Genetic Resource for Rice
2015-12-08 14:19
Takeda Presents Data from Phase 3 TOURMALINE-MM1 Study for NINLARO® (ixazomib), First and Only Once-Weekly Oral Proteasome Inhibitor Recently Approved for Multiple Myeloma
2015-12-07 16:02
Takeda Reports Five-Year Overall Survival Data for ADCETRIS® (Brentuximab Vedotin) Demonstrate Durable Remissions in Relapsed/Refractory Hodgkin Lymphoma
2015-12-04 17:59
Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea
2015-12-04 16:18
Allied World Announces Enhanced Coverage Options for Healthcare Organizations
2015-12-03 10:39
Boehringer Ingelheim and MD Anderson Cancer Center join forces to discover new treatment approaches for pancreatic cancer
2015-12-02 14:07
The Asian Acne Board and Galderma Join Forces to Improve Understanding and Management of Acne
2015-12-01 13:09
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
2015-12-01 09:19
Lung cancer experts call for improved EGFR mutation testing to allow all eligible NSCLC patients access to personalised treatment
2015-11-26 17:49
Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)
2015-11-24 10:01
ADDING MULTIMEDIA U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma
2015-11-24 09:11
Pfizer and Allergan to Combine
2015-11-23 13:46
New Survey Showed GI Health and Anti-Aging Benefits of Morinaga's Probiotics Milk with BB536
2015-11-23 11:27
Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept Biosimilar in the European Union
2015-11-19 10:26
Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
2015-11-19 10:18
Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
2015-11-18 14:44
India’s Leading Maternity and Birthing Care Hospital Group, Cloudnine, Adopts Masimo SET® Technology to Screen Infants for CCHD
2015-11-18 14:30
Pharco Pharmaceuticals Inc. Reports Ravidasvir Achieved 100% Cure Rate to Date When Combined with Sofosbuvir for HCV, Non-Cirrhotic, Genotype 4 Patients
2015-11-18 09:42
GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide
2015-11-18 09:25
Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance
<< First
< Previous
187
188
189
190
191
192
193
194
195
196
Next >
Last >>
31213
31209
31206
31204
31201
31187
31181
31168
31164
31149
31129
31128
31120
31115
31097
31096
31085
31084
31075
31074
Business Wire Weibo
Press Releases
Education
Sports
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Art and Culture
Legal
Latest Releases
2024-04-29 17:33
Al Shindagha Museum - A Modern Journey through Dubai's Rich Heritage and Cultural Tapestry
2024-04-29 13:21
Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040 Conformal Coating System
2024-04-29 13:16
Gradiant Launches CURE Chemicals for the World’s Essential Industries
2024-04-29 13:13
AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
2024-04-29 13:04
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit